• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于评估肾细胞癌预后的分级系统比较。

Comparison of grading systems for estimating the prognosis of renal cell carcinoma.

作者信息

Usubütün A, Uygur M C, Ayhan A, Toklu C, Sahin A, Ozen H, Ruacan S

机构信息

Department of Pathology, Hacettepe University, School of Medicine, Ankara, Turkey.

出版信息

Int Urol Nephrol. 1998;30(4):391-7. doi: 10.1007/BF02550216.

DOI:10.1007/BF02550216
PMID:9821039
Abstract

In this study histologic slides of 165 patients who were diagnosed as RCC between 1983 and 1993 were re-evaluated and each tumour was graded according to Thoenes, Fuhrman, Arner and Skinner's grading systems. According to Thoenes' system, patients with grade (G) 2 and 3 tumours had significantly shorter survival compared to patients with G 1 tumours. The survival difference between the subgroups of Fuhrman and Skinner's grading systems did not reach statistical significance. When the histologic differentiation was grouped as low grade (G 1&2) and high grade (G 3&4) tumours in Fuhrman and Skinner's systems, a statistically significant difference was noted between the groups in terms of survival.

摘要

在本研究中,对1983年至1993年间被诊断为肾细胞癌的165例患者的组织学切片进行了重新评估,并根据托内斯、富尔曼、阿纳和斯金纳的分级系统对每个肿瘤进行分级。根据托内斯系统,2级和3级肿瘤患者的生存期明显短于1级肿瘤患者。富尔曼和斯金纳分级系统亚组之间的生存差异未达到统计学意义。当在富尔曼和斯金纳系统中将组织学分化分为低级别(1级和2级)和高级别(3级和4级)肿瘤时,两组之间在生存期方面存在统计学显著差异。

相似文献

1
Comparison of grading systems for estimating the prognosis of renal cell carcinoma.用于评估肾细胞癌预后的分级系统比较。
Int Urol Nephrol. 1998;30(4):391-7. doi: 10.1007/BF02550216.
2
Percentage of high-grade carcinoma as a prognostic indicator in patients with renal cell carcinoma.高级别癌作为肾细胞癌患者预后指标的百分比
Cancer. 2008 Aug 1;113(3):477-83. doi: 10.1002/cncr.23574.
3
A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade.一种新型肾嫌色细胞癌分级方案:预后效用及与 Fuhrman 核分级的比较。
Am J Surg Pathol. 2010 Sep;34(9):1233-40. doi: 10.1097/PAS.0b013e3181e96f2a.
4
Application of simplified Fuhrman grading system in clear-cell renal cell carcinoma.简化的 Fuhrman 分级系统在透明细胞肾细胞癌中的应用。
BJU Int. 2011 Feb;107(3):409-15. doi: 10.1111/j.1464-410X.2010.09561.x. Epub 2010 Aug 26.
5
Clear cell renal cell carcinoma: validation of World Health Organization/International Society of Urological Pathology grading.透明细胞肾细胞癌:世界卫生组织/国际泌尿病理学会分级的验证。
Histopathology. 2017 Dec;71(6):918-925. doi: 10.1111/his.13311. Epub 2017 Oct 2.
6
Prognostic ability of simplified nuclear grading of renal cell carcinoma.肾细胞癌简化核分级的预后能力
Cancer. 2007 Mar 1;109(5):868-74. doi: 10.1002/cncr.22463.
7
Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma.根据福尔曼系统进行的原发和复查核分级:对388例传统型肾细胞癌患者的多变量分析
Cancer. 2005 Jan 1;103(1):68-75. doi: 10.1002/cncr.20749.
8
Collecting system invasion and Fuhrman grade but not tumor size facilitate prognostic stratification of patients with pT2 renal cell carcinoma.收集系统侵犯和 Fuhrman 分级而不是肿瘤大小有助于对 pT2 肾细胞癌患者进行预后分层。
J Urol. 2011 Dec;186(6):2175-81. doi: 10.1016/j.juro.2011.07.105. Epub 2011 Oct 19.
9
Grading of clear cell renal cell carcinoma should be based on nucleolar prominence.透明细胞肾细胞癌的分级应基于核仁明显度。
Am J Surg Pathol. 2011 Aug;35(8):1134-9. doi: 10.1097/PAS.0b013e318220697f.
10
Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population.与普通人群中的肾细胞癌(RCC)相比,终末期肾病患者的 RCC 具有许多有利的临床、病理和预后特征。
Eur Urol. 2011 Aug;60(2):366-73. doi: 10.1016/j.eururo.2011.02.035. Epub 2011 Mar 2.

引用本文的文献

1
18-F fluorodeoxyglucose uptake in positron emission tomography as a pathological grade predictor for renal clear cell carcinomas.正电子发射断层扫描中18-F氟脱氧葡萄糖摄取作为肾透明细胞癌病理分级预测指标
Eur Radiol. 2015 Oct;25(10):3009-16. doi: 10.1007/s00330-015-3687-2. Epub 2015 Apr 9.
2
Intraobserver and interobserver variability of Fuhrman and modified Fuhrman grading systems for conventional renal cell carcinoma.Fuhrman 分级系统和改良 Fuhrman 分级系统在常规肾细胞癌中的观察者内和观察者间变异性。
Kaohsiung J Med Sci. 2009 Nov;25(11):596-600. doi: 10.1016/S1607-551X(09)70562-5.

本文引用的文献

1
Prognostic factors in renal cancer.
Urol Clin North Am. 1993 May;20(2):247-62.
2
Stage I renal cell carcinoma. A clinicopathologic study of 82 cases.I期肾细胞癌。82例临床病理研究。
Am J Surg Pathol. 1993 Mar;17(3):275-86. doi: 10.1097/00000478-199303000-00008.
3
Multivariate evaluation of prognostic determinants for renal cell carcinoma.
Urol Int. 1993;50(1):6-12. doi: 10.1159/000282439.
4
Prognostic significance of morphologic parameters in renal cell carcinoma.
肾细胞癌形态学参数的预后意义
Am J Surg Pathol. 1982 Oct;6(7):655-63. doi: 10.1097/00000478-198210000-00007.
5
Stratification of risk factors in renal cell carcinoma.
Cancer. 1983 Sep 1;52(5):899-903. doi: 10.1002/1097-0142(19830901)52:5<899::aid-cncr2820520526>3.0.co;2-#.
6
Well differentiated (grade 1) clear cell renal carcinoma.高分化(1级)透明细胞肾细胞癌。
J Urol. 1983 May;129(5):933-7. doi: 10.1016/s0022-5347(17)52464-7.
7
The results of radical nephrectomy for renal cell carcinoma.肾细胞癌根治性肾切除术的结果。
J Urol. 1969 Mar;101(3):297-301. doi: 10.1016/s0022-5347(17)62331-0.
8
Renal adenocarcinoma; morphology--grading of malignancy--prognosis. A study of 197 cases.肾腺癌;形态学——恶性程度分级——预后。197例病例研究。
Acta Chir Scand Suppl. 1965;346:1-51.
9
Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases.肾细胞癌的诊断与管理。309例临床与病理研究。
Cancer. 1971 Nov;28(5):1165-77. doi: 10.1002/1097-0142(1971)28:5<1165::aid-cncr2820280513>3.0.co;2-g.
10
Renal cell carcinoma: survival and prognostic factors.肾细胞癌:生存率及预后因素
Urology. 1986 Apr;27(4):291-301. doi: 10.1016/0090-4295(86)90300-6.